Dismiss Notice
Links from our daily front page news are now being fed to this board. If you want to comment on any of the news articles, you can now do so there.

Retina

Discussion in 'Genentech' started by anonymous, May 31, 2017 at 6:23 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Any thoughts?
     
  2. anonymous

    anonymous Guest

    It's a great place to be.
     
  3. anonymous

    anonymous Guest

    It seems there are a lot of changes taking place all to quickly, what's up with that?
     
  4. anonymous

    anonymous Guest

    DYING franchise. Heck had big RIF right before the NSM LV bash in Jan 2016. Worst enemy is the heck of lot cheaper (and as safe) diluted Avastin. Just wait till Avastin biosimilars from big pharmas hit the market soon as it will be death kneel to Retina reps.
     
  5. anonymous

    anonymous Guest

    I call bullcrap. At best, the biosimilar will be 75% of the price
     
  6. anonymous

    anonymous Guest

  7. anonymous

    anonymous Guest

    This franchise has a bright future. Genentech supports ophthalmology and will continue to invest. More indications than competitor. Great place to be!
     
  8. anonymous

    anonymous Guest

    thanks Anand
     
  9. anonymous

    anonymous Guest

    it is a great place to be ......and your welcome. -A
     
  10. anonymous

    anonymous Guest

    Just got a call from a recruiter for a possible opening or expansion later this year but no details. What's the story?
     
  11. anonymous

    anonymous Guest

    no story, either an open territory or nothing else
     
  12. anonymous

    anonymous Guest

    My understanding was that it was for a new drug, possibly lampalizumab?
     
  13. anonymous

    anonymous Guest

    With the lampalizumab trial not meeting primary endpoint, what is the future of this franchise?
     
  14. anonymous

    anonymous Guest

    Get by till Avastin biosims become viable alternate then jump ship.
     
  15. anonymous

    anonymous Guest